West Pharmaceutical Services, Inc.
DE ˙ DB ˙ GB00BLGXWY71
266,50 € ↓ -2,60 (-0,97%)
2026-06-03
DEL PRIS
SecurityDE:WPS / West Pharmaceutical Services, Inc.
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership3,215 shares
Latest Disclosed Value $ 805,808
Engineers Gate Manager LP reports 71.86% decrease in ownership of WPS / West Pharmaceutical Services, Inc.

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 3,215 shares of West Pharmaceutical Services, Inc. (DE:WPS) valued at $686,402 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 11,427 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -71.86% during the quarter. The current value of the position is $856,798 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,215 -8,212 -71.86 806 -74.40 0.0101
2026-02-17 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 11,427 8,692 317.81 3,144 338.49 0.0373
2025-11-14 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,735 -46,113 -94.40 717 -93.29 0.0082
2025-08-14 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 48,848 47,286 3,027.27 10,688 2,962.18 0.1330
2025-05-15 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,562 1,562 350 0.0059
2025-02-14 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -692 -100.00 0 -100.00
2024-11-14 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 692 692 208 0.0041
2024-05-15 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -22,772 -100.00 0 -100.00
2024-02-14 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 22,772 21,855 2,383.32 8,018 2,230.81 0.2289
2023-11-14 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 917 -675 -42.40 344 -43.42 0.0127
2023-08-14 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,592 1,592 609 0.0230
2023-02-14 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -24,578 -100.00 0 -100.00
2022-11-14 2022-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 24,578 10,940 80.22 6,048 46.65 0.3763
2022-08-15 2022-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 13,638 13,638 4,124 0.1512
2022-02-14 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -1,461 -100.00 0 -100.00
2021-11-15 2021-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,461 143 10.85 620 31.08 0.0353
2021-08-16 2021-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,318 186 16.43 473 48.28 0.0304
2021-05-17 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,132 14 1.25 319 0.63 0.0158
2021-02-16 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,118 -19,574 -94.60 317 -94.43 0.0137
2020-11-16 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 20,692 17,966 659.06 5,688 818.90 0.2669
2020-08-17 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,726 -3,181 -53.85 619 -31.15 0.0315
2020-05-15 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,907 5,907 899 0.0648
2020-02-14 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -3,684 -100.00 0 -100.00
2019-11-14 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,684 -1,680 -31.32 522 -22.21 0.0265
2019-08-14 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,364 5,364 671 0.0370
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.